Access cutting-edge hepatitis c (hcv) treatment through this clinical trial at a research site in Cranston. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Cranston location
Preparing your pre-screening questions…
Access hepatitis c (hcv) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hepatitis c (hcv) treatment provided free
Check if you qualify for this hepatitis c (hcv) clinical trial in Cranston, RI
No-Cost Study Care
Local to Cranston
Convenient for RI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this clinical trial is to learn whether a low-barrier treatment program can help people with hepatitis C virus (HCV) who are in jail start and complete treatment more easily. This study focuses on adults at the Rhode Island Department of Corrections who have active HCV and are awaiting trial. The study asks: * Can a simplified, low-barrier HCV treatment program work in a jail setting? * Do participants finish treatment and get cured using this approach? All participants will receive a 12-week course of the HCV medication sofosbuvir/velpatasvir (Epclusa). If they are released before completing treatment, they will take the remaining doses with them. Community Health Workers (CHWs) will help support participants after release, including reminding them to take medications and helping them get follow-up lab work. Researchers will measure: * Whether participants are cured of HCV * Whether the treatment approach is easy to use (feasible), acceptable, and followed correctly (fidelity) * Whether the program could be used in other jails or expanded in the future This study may help bring HCV treatment to more people in jail, reduce community spread of the virus, and support national goals to eliminate HCV.
Sponsor: Lifespan
Yes, this clinical trial (NCT06953479) has an active research site in Cranston, RI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hepatitis c (hcv) treatment options in Cranston, RI, this clinical trial (NCT06953479) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Cranston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hepatitis c (hcv) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all hepatitis c (hcv) clinical trials near you to find additional studies recruiting in your area.
See all hepatitis c clinical trials recruiting in Cranston — not just this study.
Browse Hepatitis C Trials in Cranston →